tradingkey.logo
搜索

AtriCure Inc

ATRC
添加自选
28.120USD
-0.030-0.11%
收盘 05/15, 16:00美东报价延迟15分钟
1.42B总市值
亏损市盈率 TTM

AtriCure Inc

28.120
-0.030-0.11%
查看详细走势图
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-0.11%

5天

+7.00%

1月

-2.63%

6月

-14.53%

今年开始到现在

-28.92%

1年

-14.03%

TradingKey AtriCure Inc股票评分

单位: USD 更新时间: 2026-05-15

操作建议

AtriCure Inc当前公司基本面数据相对非常健康,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在医疗设备与耗材行业排名19/206位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价49.38。中期看,股价处于下降通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

AtriCure Inc评分

相关信息

行业排名
19 / 206
全市场排名
84 / 4482
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看好

AtriCure Inc亮点

亮点风险
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
业绩高增长
公司营业收入稳步增长,连续3年增长33.88%
估值低估
公司最新PE估值-295.50,处于3年历史低位
机构减仓
最新机构持股48.18M股,环比减少12.70%
景顺投资公司持仓
明星投资者景顺投资公司持仓,最新持仓市值52.05K
活跃度增加
近期活跃度增加,过去20天平均换手率0.44

分析师目标

根据 10 位分析师
买入
评级
49.375
目标均价
+75.40%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

AtriCure Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

AtriCure Inc简介

AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
公司代码ATRC
公司AtriCure Inc
CEOCarrel (Michael H)
网址https://www.atricure.com
KeyAI